Show an ad over header. AMP

I am the FIRST!!!

Rep. Letlow on losing husband to COVID: "I would've given anything" for the vaccine

Rep. Julia Letlow, whose husband, Luke, died of COVID-19 in December, made an emotional, urgent plea on "CBS This Morning" for more Louisiana residents to get the coronavirus vaccine as the state faces a surge in new cases.

Driving the news: "He and I had prayed for weeks prior about the possibility of the vaccine and we were so excited that it was coming out and that it was going to be widely available," Letlow said in an interview that aired Wednesday. "And he missed it by two weeks."


  • Luke Letlow was elected to Congress in a Dec. 5 runoff election. He died from COVID-19 complications on Dec. 29, just days before he was set to be sworn in. Julia Letlow won a special election on March 20 to replace her late husband.

What she's saying: Letlow, whose state of Louisiana is experiencing an uptick of COVID-19 cases and low-levels of vaccinations, is using her husband's story to encourage residents to get the vaccine.

  • "It all happened very quickly. He was very aware and cognizant and speaking to people and then he kind of crossed over a threshold, where I started to see the color drain. And that's when it hit me that he might not come home," Letlow told CBS.
  • "I would've given anything, I would've given everything for that shot to be available to us. Looking back now, and for someone to turn it away, it's heartbreaking to me," she said.

The big picture: Louisianarecorded2,112 COVID-19 hospitalizations on Wednesday, breaking the previous record of 2,069 set on Jan. 7, according to WAFB.

  • The Louisiana Department of Health also reported 4,725 new cases and 59 new deaths.
  • About 37% of the eligible population in Louisiana has been vaccinated, per Our World in Data.

regular 4 post ff

infinite scroll 4 pff

Employees grapple with re-entry anxiety as jobs call them back

Pandemic-related anxieties are entering a new phaseas more employers start to call vaccinated workers back into their offices.

Why it matters: Some employees simply don't want to go back to the office; some are desperate to. Some are struggling to rearrange their routines yet again; some don't have that flexibility. And everyone — employers and employees alike — is figuring out on the fly how to make it work.

Keep reading...Show less

Biden's push for fiber revives a Google dream

President Biden's plan to boost broadband across the country could also be a boon to Google's internet ambitions.

Why it matters: Biden wants to invest billions in building "future-proof" networks to connect all Americans, using a technology that Google previously struggled to deploy widely.

Keep reading...Show less

Mark Warner emerges as moderates' dealmaker-in-chief

As Senate Majority Leader Chuck Schumer (D-N.Y.) and White House Chief of Staff Ron Klain navigate the legislative minefield of the next few months, they'll often turn to a moderate Democrat who gets far less ink than Sens. Joe Manchin (D-W.Va.) or Kyrsten Sinema (D-Ariz.).

The big picture: Sen. Mark Warner (D-Va.) has become a pivotal player in the multi-trillion-dollar negotiations that will shape the Democrats' electoral prospects, Joe Biden's presidency and the future of the country.

Keep reading...Show less

FDA calls for independent review of Alzheimer's drug approval

FDA Acting Commissioner Janet Woodcock on Friday formally asked the HHS' Office of Inspector General to "conduct an independent review and assessment of interactions between representatives of Biogen and FDA during the process that led to the approval of Aduhelm."

Why it matters: Aduhelm has been one of the most controversial drug approvals in recent memory. The rare move from the agency comes on the heels of a STAT News report that detailed how Biogen and FDA officials worked closely during the process, and possibly violated FDA rules with an "off-the-books" meeting.

Insights

mail-copy

Get Goodhumans in your inbox

Most Read

More Stories
<!ENTITY lol2 “&lol;&lol;&lol;&lol;&lol;&lol;&lol;&lol;&lol;&lol;“> <!ENTITY lol3 “&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;“> <!ENTITY lol4 “&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;“> ]> &lol4;